Imricor Medical Systems, Inc. (ASX:IMR)

Market Cap	471.79M
Revenue (ttm)	1.14M
Net Income (ttm)	-54.87M
Shares Out	320.95M
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,234
Average Volume	176,729
Open	1.475
Previous Close	1.470
Day's Range	1.465 - 1.485
52-Week Range	1.080 - 1.855
Beta	0.11
RSI	54.32
Earnings Date	Feb 25, 2026

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to min...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2024, Imricor Medical Systems's revenue was $959,424, an increase of 55.86% compared to the previous year's $615,568. Losses were -$29.69 million, 31.2% more than in 2023.

Financial numbers in USD